Anomaly Bio raises $2.6M in pre-seed funding led by Pebblebed Ventures to enhance biomanufacturing R&D and establish new facilities in Singapore.
Amount Raised
$2.6 Million
Round Type
Pre-Seed
Investors
Description
Anomaly Bio, a Singapore-based biotech startup, has raised US$2.6 million in pre-seed funding led by Pebblebed Ventures. The funding will support the establishment of a laboratory and pilot-scale facilities for biomanufacturing innovation. The company plans to leverage existing fermentation infrastructure to enhance production cycles. Anomaly Bio aims to tackle ingredient supply chain challenges through sustainable practices.
Quick answer
Anomaly Bio raised $2.6 Million in a Pre-Seed round, dated November 12, 2025. Investors: Akshay Kothari, Sean Hunt, Eben Bayer, Mithun Sacheti and Pebblebed Ventures.
- How much did Anomaly Bio raise?
- Anomaly Bio raised $2.6 Million in a Pre-Seed round on November 12, 2025.
- Who invested in Anomaly Bio?
- Akshay Kothari, Sean Hunt, Eben Bayer, Mithun Sacheti and Pebblebed Ventures are named as investors in this round.
- What does Anomaly Bio do?
- Anomaly Bio is a Singapore-based biotech startup founded in 2022 at the National University of Singapore (NUS).
- Where is Anomaly Bio based and how big is it?
- Fundz records about 2 employees.
- Who are the decision-makers at Anomaly Bio?
- Fundz holds 1 contact at Anomaly Bio, including the Co-Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as Anomaly Bio that raised within 45 days of this round, from Fundz verified event records.
- IBI Ag raised $10M (Series A) on November 11, 2025.
- Brainstorm Cell Therapeutics raised $155K (Convertible Note) on November 6, 2025.
- arcoris bio raised $6.7M (Seed) on November 6, 2025.
- Hepta raised $6.7M (Seed) on November 5, 2025.
- nextProtein raised $21M (Series B) on November 4, 2025.
- AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
Who to call at Anomaly Bio, and when
A new round usually means Anomaly Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Anomaly Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Anomaly Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Anomaly Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Anomaly Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Anomaly Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.